SCM
PFE icon

SCS Capital Management’s Pfizer PFE Stock Holding History

SCS Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$831K Sell
29,591
-669
-2% -$17.8K 0.01% 300
2025
Q4 		$753K Buy
30,260
+228
+0.8% +$5.75K 0.01% 312
2025
Q3 		$765K Sell
30,032
-524
-2% -$12.9K 0.01% 317
2025
Q2 		$741K Sell
30,556
-160
-0.5% -$3.73K 0.01% 322
2025
Q1 		$778K Buy
+30,716
New +$804K 0.01% 288

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

SCS Capital Management's PFE Position: Q1 2026 in Review

SCS Capital Management reduced its Pfizer (PFE) stake by 2.2% in Q1 2026, selling an estimated $17.8K and leaving 29,591 shares worth $831K. The position accounts for 0.01% of the portfolio, ranked #300.

SCS Capital Management first reported a position in PFE in Q1 2025 and has held it in 5 quarters since. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • SCS Capital Management held 29,591 shares of Pfizer worth $831K as of Q1 2026.
  • SCS Capital Management sold 669 Pfizer shares in Q1 2026, an estimated $17.8K.
  • Pfizer made up 0.01% of SCS Capital Management's portfolio in Q1 2026, its #300 holding.
  • SCS Capital Management first reported a position in Pfizer in Q1 2025 and has held it in 5 quarters since.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on SCS Capital Management's 13F filing for Q1 2026, filed 11 May 2026.